Dipika Kakkar will soon begin targeted therapy—a part of her liver cancer treatment—a month after she underwent surgery for ...

Australians aged in their 30s and 40s are experiencing unprecedented and in some cases world-leading rates of 10 different ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

Lung cancer cases are on the rise in non-smokers around the world, and air pollution could be an insidious, contributing ...

Dealing with these decisions isn’t easy while undergoing cancer treatment. But yes, it’s completely understandable to ...

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

Scientists with the NIH-backed SMaHT Network are mapping every DNA mutation in the human body, creating a groundbreaking ...

Researchers working on an incurable blood cancer can now use a new lab model that could make testing potential new treatments and diagnostics easier and quicker, new research has found.

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Dizal's oral EGFR inhibitor Zegfrovy (sunvozertinib) as a treatment for patients with locally advanced or ...

Biomodal reports methylation sequencing is expanding the window for early detection.

The approval of sunvozertinib, an oral irreversible EGFR inhibitor, was supported by data from the WU-KONG1B trial (ClinicalTrials.gov Identifier: NCT03974022 ). The primary efficacy population ...

Rare, deadly, and often missed, some skin cancers develop in areas that rarely see the sun. Scientists are still learning about them, but here's what we know.